Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C117 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Tuesday 04/16/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | Bluebird 2E-H
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Ronald C. Petersen, PhD, MD, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants should become familiar with the construct of mild cognitive impairment, identify criteria for the diagnosis of MCI, use MCI as a clinical syndrome, differentiate underlying causes of MCI for treatment, develop a program for evaluating patients for pharmacotherapy, and evaluate the longitudinal outcome of patients with MCI.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Brain Health
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM MDT Speaker Mild Cognitive Impairment: Overview
Ronald C. Petersen, PhD, MD, FAAN
01:30 PM - 02:00 PM MDT Speaker Atypical Presentations of MCI
Oscar L. Lopez, MD, FAAN
02:00 PM - 02:30 PM MDT Speaker Treatment of MCI
David J. Gill, MD, FAAN
02:30 PM - 03:00 PM MDT Speaker Case Discussion
Ronald C. Petersen, PhD, MD, FAAN, Oscar L. Lopez, MD, FAAN, David J. Gill, MD, FAAN
Faculty Disclosures
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck.
David J. Gill, MD, FAAN Dr. Gill has nothing to disclose.